Pfizer’s antibiotic combination receives EC approval to treat multidrug-resistant infections
Antimicrobial resistance has been declared by WHO as one of the top ten threats to global health
Read More
Apr 23, 2024 | News, Regulatory
Antimicrobial resistance has been declared by WHO as one of the top ten threats to global health
Read MoreApr 23, 2024 | News, Regulatory
The regulator’s decision marks Bimzelx’s fourth approved indication within the EU
Read MoreApr 23, 2024 | News, Regulatory
Inflammatory bowel disease affects around ten million people worldwide
Read MoreThe company was presented with the award in recognition of its Glucowear device
Read MoreThe agreement gives Ipsen an option to receive exclusive global rights to two candidates
Read MoreApr 22, 2024 | News, Regulatory
More than 4,500 new patients are diagnosed with this form of blood cancer every year in the UK
Read MoreApr 22, 2024 | News, Regulatory
The acute diarrhoeal illness was reported to affect around 473,000 people in 2022
Read MoreThe progressive neurodegenerative disease affects seven million people worldwide
Read MoreApr 19, 2024 | Regulatory, News
Approximately half of all patients with early lung cancer experience cancer recurrence following surgery
Read MoreThe Paddington site will serve as one of the company’s three global hubs
Read MoreThe infectious condition affects up to one in three people globally in their lifetimes
Read MoreThe three major types of skin cancer are basal cell carcinoma, squamous cell carcinoma and melanoma
Read MoreAccount Specialist - Respiratory - Kent & Medway
Integrated Care Specialist - North & West Yorkshire
Hospital Specialist - East Midlands
Territory Sales Manager - Yorkshire/North East